OnDemand WTP Pricing Research

Tag: Strategic Pricing

Congress Is Right: Patent Abuse Is Medical Malpractice | Newsmax

Congress Is Right: Patent Abuse Is Medical Malpractice | Newsmax

The House Committee on Energy and Commerce’s Oversight and Investigations Subcommittee recently concluded its second hearing this month on the soaring cost of insulin. With insulin manufacturers’ price-gouging now leading some diabetics with no choice but to dangerously self-ration their medicine, reportedly leading to deaths, it could not have come at a better time, NPR […]

Priority Review Vouchers Have Helped To Improve Access To Drugs Targeting Neglected Diseases | Forbes

Priority Review Vouchers Have Helped To Improve Access To Drugs Targeting Neglected Diseases | Forbes

The Food and Drug Administration’s (FDA) Priority Review Vouchers (PRVs) for neglected tropical diseases (NTDs) are aimed to incentivize pharmaceutical companies to develop drugs or vaccines for NTDs. The vouchers do this by providing a six-month expedited review of another drug within that company’s development pipeline if they receive FDA approval for such a drug […]

Controlling stent prices may show benefits in short-run, but does long-term damage | The Financial Express

Controlling stent prices may show benefits in short-run, but does long-term damage | The Financial Express

A new study by doctors and policymakers at public hospitals posits that the price cap on coronary stents may have helped a larger number of patients from lower-income groups undergo life-saving angioplasty since their number went up sharply after the price-regulation move. The study, led by Dr Bhanu Duggal, the head of cardiology at AIIMS, […]

Common Mistakes to Avoid in a Profitability Overhaul | Modern Distribution Management

Common Mistakes to Avoid in a Profitability Overhaul | Modern Distribution Management

Claims vs. Reality In examining pricing strategy, members of the sales team will often say a distributor is overpriced in the market — don’t buy that claim, said Real Results Marketing Managing Partner Jonathan Bein, Ph.D. His company has done years of customer research that shows pricing is not a top factor for clients. When […]

New drug pricing analysis reveals where PBMs and pharmacies make their money | 46brooklyn Research

New drug pricing analysis reveals where PBMs and pharmacies make their money | 46brooklyn Research

For those uninitiated, 46brooklyn Research was founded by two Ohio pharmacy guys who had seen enough problems in the prescription drug supply chain to know that transparency and accountability were sorely needed. Prior to our launch in August 2018, we spent months digging into publicly-available data to expose a growing gap between the actual price […]

Drugmakers Reveal List Prices Online After Pressure From Trump | Bloomberg

Drugmakers Reveal List Prices Online After Pressure From Trump | Bloomberg

The world’s biggest pharmaceutical companies are revealing prices of their prescription drugs on websites for the first time in a bid to stave off pressure from the Trump administration to make even more public disclosures. The move by companies ranging from pharma giant Pfizer Inc. to biotechnology pioneer Amgen Inc. comes almost a year after […]

Drugmakers Reveal List Prices Online After Pressure From Trump | Bloomberg

Drugmakers Reveal List Prices Online After Pressure From Trump | Bloomberg

The world’s biggest pharmaceutical companies are revealing prices of their prescription drugs on websites for the first time in a bid to stave off pressure from the Trump administration to make even more public disclosures. The move by companies ranging from pharma giant Pfizer Inc. to biotechnology pioneer Amgen Inc. comes almost a year after […]

Lannett: Generic Price Gouging Suit Names Names, Might Be The Death Blow – Lannett Company, Inc. (NYSE:LCI) | Seeking Alpha

Lannett: Generic Price Gouging Suit Names Names, Might Be The Death Blow – Lannett Company, Inc. (NYSE:LCI) | Seeking Alpha

Summary The State of Connecticut recently had the court release an unredacted version of their previously filed charges against LCI, MYL and others. The charges filed allege that current LCI employees were colluding with PAR (while the current Chairman of the BOD was in the same role at PAR). The range of potential fines is […]

Point of View: Time to end PBM price gouging | The Oklahoman

Point of View: Time to end PBM price gouging | The Oklahoman

Prescription drug prices are out of control. For too long, large corporations have used legal loopholes to profit off of those in need, and it’s time to pass legislation to curtail these harmful practices. House Bill 2632 and Senate Bill 841 are making their way through the legislative process with the goal of giving you […]

Sarbanes calls insulin-pricing system ‘hocus pocus’ | Capital Gazette

Sarbanes calls insulin-pricing system ‘hocus pocus’ | Capital Gazette

U.S. Rep. John Sarbanes on Wednesday criticized insulin producers for their lack of transparency in setting prices. “I do not buy the argument that the patient is going to be worse off, the consumer is going to be worse off, if we have complete transparency,” the Baltimore County Democrat said at a hearing by the […]